As of 2023, the HIV-positive tuberculosis treatment success rate in Brazil stood at 55%. The forecasted data for the years 2024 to 2028 indicates a gradual improvement in treatment success rates, with a stable value of 56% from 2024 to 2026 and a slight increase to 57% in 2027 and 2028. This reflects a year-on-year growth of approximately 1.79% from 2026 to 2027. Over the five-year period from 2024 to 2028, the compound annual growth rate (CAGR) is expected to be 0.88%, showing modest improvements in treatment success.

Future trends to watch for:

Enhanced healthcare policies focusing on integrated care for HIV and tuberculosis patients.
Increased investment in healthcare infrastructure and personnel training to boost treatment efficacy.
Potential challenges due to economic factors or changes in healthcare funding and policies.